$404,477
＋4.6%
CEO and Managing Director
2024
$347k
32 hrs/wk
$59k
--
CEO and Managing Director at Bioadvance Capital
Fiscal year ended June 30, 2024. Published on January 25, 2026.
Total compensation
Shahram Hejazi has been listed as an employee of Bioadvance Capital in Form 990 filings since at least fiscal year 2016. Total compensation for Shahram Hejazi has increased by 27% from 2016 to 2024.